Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.

about

Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.

Item

http://www.wikidata.org/entity/Q42675692

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Vascular endothelial growth re ...... eutic response to thalidomide.

@en

Vascular endothelial growth re ...... eutic response to thalidomide.

@nl

type

Item

label

Vascular endothelial growth re ...... eutic response to thalidomide.

@en

Vascular endothelial growth re ...... eutic response to thalidomide.

@nl

prefLabel

Vascular endothelial growth re ...... eutic response to thalidomide.

@en

Vascular endothelial growth re ...... eutic response to thalidomide.

@nl

P1476

Vascular endothelial growth re ...... eutic response to thalidomide.

@en

P2093

Fuchun Guo

http://www.w3.org/2001/XMLSchema#string

Guoping Wang

http://www.w3.org/2001/XMLSchema#string

Qin Liu

http://www.w3.org/2001/XMLSchema#string

Tao Yin

http://www.w3.org/2001/XMLSchema#string

Yi Li

http://www.w3.org/2001/XMLSchema#string

Yongsheng Wang

http://www.w3.org/2001/XMLSchema#string

Yuhong Ou

http://www.w3.org/2001/XMLSchema#string

P2860

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis

Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library.

Cellular stress responses: cell survival and cell death

Antitumor activity of thalidomide in refractory multiple myeloma.

Thalidomide: the tragedy of birth defects and the effective treatment of disease.

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

Low-dose thalidomide in patients with metastatic renal cell carcinoma.

Heat shock proteins in cancer: chaperones of tumorigenesis.

P304

4263-4271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29075340

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

P932

5647747

http://www.w3.org/2001/XMLSchema#string